Dr Arefa Cassoobhoy provides a quick rundown of this week's news on long-term effects of gastric bypass surgery, safety of LABAs, and a new black box warning from the FDA.

Dr Richard Bergenstal describes a study designed to answer a question that has puzzled the medical community in recent years.

The complex ritual of dosing insulin will be vastly simplified with the impending arrival of closed-loop systems, better known as 'artificial pancreas.

What's the optimal drug combination for managing type 2 diabetes? It depends on the patient…

Matt Longjohn, national health officer of the YMCA, describes the very successful diabetes prevention programs administered through the YMCA and deemed reimbursable by CMS.

Do patients with type 1 diabetes benefit from continuous glucose monitoring even if they are not using an insulin pump?

Hypoglycemia remains an important preventable cause of brain damage in children; don't take it lightly.

Drs Steve Edelman and Jeremy Pettus interview 'bionic pancreas' developer Ed Damiano to get the latest information on the much-awaited device.

Eight million Americans have diabetes and don't know it. How can we persuade the public, the government, and the scientific community to focus on this invisible epidemic?

With empagliflozin, pioglitazone, and liraglutide, we may finally be getting closer to the 'holy grail' of a diabetes drug that also has cardiovascular benefits.